Mapping functional regions in the lumenal domain of the class II- associated invariant chain

The MHC class II-associated invariant chain interacts in trimeric form with class II molecules, inhibits peptide binding, and mediates targeting of class II molecules to endosomal compartments. To dissect the different functions of the invariant (Ii) chain, a set of cDNAs, encoding truncated forms of the Ii chain, was constructed. mRNAs, transcribed from these cDNAs were translated in vitro, together with mRNAs encoding class II HLA DR1 alpha and beta subunits. An Ii chain truncation that contains the 104 NH2-terminal amino acids was able to associate with class II molecules. This construct contains the region from which class II-associated Ii chain peptides (CLIP, amino acids 81- 104) are derived. The absence of a further eight residues at the COOH terminus results in a construct of 96 amino acids that is unable to associate with class II molecules. Association of the truncated Ii chains with class II molecules showed a strict correlation with inhibition of peptide binding. Removal of the NH2-terminal cytoplasmic tail and transmembrane region of Ii chain and its replacement with a cleavable signal sequence led to aberrant folding and impaired association with class II molecules. The region between amino acids 163 and 183 was found to be essential for visualization of Ii chain homotrimers by covalent cross-linking.

[1]  H. Ploegh,et al.  Assembly of HLA DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain. , 1994, The EMBO journal.

[2]  N. Koch,et al.  The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  William Arbuthnot Sir Lane,et al.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles , 1993, The Journal of experimental medicine.

[4]  P. Cresswell,et al.  HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides , 1992, Nature.

[5]  W. T. Schaiff,et al.  HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain negative cells , 1992, The Journal of experimental medicine.

[6]  William S. Lane,et al.  Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.

[7]  A Sette,et al.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.

[8]  P. Cresswell,et al.  Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. , 1992, Journal of immunology.

[9]  P. Cresswell.  Chemistry and functional role of the invariant chain , 1992, Current Biology.

[10]  M. Anderson,et al.  Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. A. Peterson,et al.  Invariant chain--a regulator of antigen presentation. , 1992, Trends in cell biology.

[12]  P. Cresswell.  Chemistry and functional role of the invariant chain. , 1992 .

[13]  P. Cresswell,et al.  Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain , 1991, Nature.

[14]  A. Rudensky,et al.  Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.

[15]  P. Cresswell,et al.  Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Germain,et al.  Invariant chain promotes egress of poorly expressed, haplotype-mismatched class II major histocompatibility complex A alpha A beta dimers from the endoplasmic reticulum/cis-Golgi compartment. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Geuze,et al.  Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments , 1991, Nature.

[18]  P. A. Peterson,et al.  Intracellular transport of class II MHC molecules directed by invariant chain , 1990, Nature.

[19]  O. Bakke,et al.  MHC class II-associated invariant chain contains a sorting signal for endosomal compartments , 1990, Cell.

[20]  P. A. Peterson,et al.  Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways , 1990, Nature.

[21]  P. Cresswell,et al.  Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens , 1990, The Journal of cell biology.

[22]  P. Cresswell,et al.  Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding , 1990, Nature.

[23]  H. Geuze,et al.  The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route , 1990, Cell.

[24]  P. van Endert,et al.  Human major histocompatibility complex class II invariant chain is expressed on the cell surface. , 1990, The Journal of biological chemistry.

[25]  Eric O Long,et al.  Structural model of HLA-DR1 restricted T cell antigen recognition , 1988, Cell.

[26]  B. Mach,et al.  Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen‐associated invariant chain. , 1986, The EMBO journal.

[27]  P. Cresswell.  Intracellular class II HLA antigens are accessible to transferrin-neuraminidase conjugates internalized by receptor-mediated endocytosis. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[28]  H. Mcdevitt,et al.  DNA sequence and characterization of human class II major histocompatibility complex beta chains from the DR1 haplotype. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[29]  V. Quaranta,et al.  A human Ia cytoplasmic determinant located on multiple forms of invariant chain (gamma, gamma 2, gamma 3). , 1984, Journal of immunology.

[30]  D. Larhammar,et al.  cDNA clone for the human invariant gamma chain of class II histocompatibility antigens and its implications for the protein structure. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Cresswell,et al.  Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens. , 1982, Journal of immunology.

[32]  D. Larhammar,et al.  Alpha chain of HLA-DR transplantation antigens is a member of the same protein superfamily as the immunoglobulins , 1982, Cell.

[33]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[34]  P. Cresswell,et al.  Assembly, transport, and function of MHC class II molecules. , 1994, Annual review of immunology.

[35]  H. Mcdevitt,et al.  DNA sequence and characterization of human class II major histocompatibility complex 8 chains from the DRI haplotype , 2022 .